Wilate – von Willebrand Factor/Coagulation Factor VIII Complex (Human) (Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.)


Welcome to the PulseAid listing for the Wilate – von Willebrand Factor/Coagulation Factor VIII Complex (Human) drug offered from Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.. This Human Antihemophilic Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient],Factor VIII [Chemical/Ingredient],Human Blood Coagulation Factor [EPC],Increased Platelet Aggregation [PE],Increased Coagulation Activity [PE],von Willebrand Factor [Chemical/Ingredient],Blood Coagulation Factors [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
NON-PROPRIETARY NAME: von Willebrand Factor/Coagulation Factor VIII Complex (Human)
SUBSTANCE NAME: ANTIHEMOPHILIC FACTOR HUMAN; VON WILLEBRAND FACTOR HUMAN
TYPE: PLASMA DERIVATIVE
PHARMA CLASS: Human Antihemophilic Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient],Factor VIII [Chemical/Ingredient],Human Blood Coagulation Factor [EPC],Increased Platelet Aggregation [PE],Increased Coagulation Activity [PE],von Willebrand Factor [Chemical/Ingredient],Blood Coagulation Factors [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2009-12-04
END MARKETING DATE: 0000-00-00


Wilate – von Willebrand Factor/Coagulation Factor VIII Complex (Human) PLASMA DERIVATIVE Details:

Item DescriptionWilate – von Willebrand Factor/Coagulation Factor VIII Complex (Human) from Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
LABELER NAME: Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
DEA SCHEDULE:
ACTIVE STRENGTH: 100; 100([iU]/mL; [iU]/mL)
START MARKETING DATE: 2009-12-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67467-182_aae10ecc-a31e-d699-eff2-7540089705c4
PRODUCT NDC: 67467-182
APPLICATION NUMBER: BLA125251

Other ANTIHEMOPHILIC FACTOR HUMAN; VON WILLEBRAND FACTOR HUMAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.Wilate – von Willebrand Factor/Coagulation Factor VIII Complex (Human)
Octapharma USA IncWilate – von Willebrand Factor/Coagulation Factor VIII Complex (Human)